Nao-Xue-Shu Oral Liquid Protects and Improves Secondary Brain Insults of Hypertensive Cerebral Hemorrhage

Table 2

Quantitative changes of interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), and the volume of hematoma before and after the additional treatment in the treatment and control groups.

Group	Time points	IL-6 (pg/mL)	TNF-α (pg/mL)	Volume (mL)
Treatment ()	Baseline	84.26 ± 12.47	186.92 ± 36.55	38.64 ± 14.52
	Week 1	53.83 ± 27.64	121.34 ± 27.66	29.37 ± 10.58
	Week 2	21.08 ± 15.39	73.59 ± 36.72	17.81 ± 9.37
Control ()	Baseline	87.09 ± 12.47	183.33 ± 43.35	36.91 ± 19.37
	Week 1	72.63 ± 25.58	169.28 ± 35.91	31.96 ± 13.86
	Week 2	50.71 ± 19.07	108.35 ± 45.49	25.95 ± 12.36

Note: , , and compared with baseline of the same group; ^#, ^##, and ^### compared with control group for the same time points.